Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
CGD NOTES
May 31, 2024
CGD NOTES
June 05, 2024
CGD NOTES
May 23, 2024
WORKING PAPERS
June 05, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
CGD NOTES
March 15, 2024
The November guidance on RSF seems to have addressed some of the shortcomings observed in the initial RSF programs. However, as we highlight in this note, other deficiencies remain unresolved and require attention from the IMF’s Executive Board during the upcoming RSF review.
CGD NOTES
August 23, 2023
Across several African countries, there has been a troubling trend of infrastructure being stripped to sell as scrap metal. People have been arrested for ripping out and selling rail sleepers in South Africa and Ghana, pylon and copper wires in Uganda, and streetlamp meters in Liberia. That strippin...
BRIEFS
July 17, 2023
In the fall of 2022, World Bank shareholders (member governments, including the United States) called for a suite of reforms aimed at better enabling the institution to respond to today’s global development challenges, such as pandemics, climate change, and natural disasters. The World Bank is one o...
CGD NOTES
April 08, 2021
As the Biden administration turns its attention to infrastructure legislation in the United States, it is important to focus on the role investment in infrastructure financing can play in the recovery. This note covers a policy proposal for a credit enhancement instrument, using concessional financi...
WORKING PAPERS
January 25, 2016
Many developing countries need the World Bank’s capital less and less. What role should the Bank play in the 21st century? This paper argues that many features of the Bank today reflect a new role. That role, resting on the economic theory of bargaining and public good provision, is to reduce ...
WORKING PAPERS
July 15, 2013
We argue that in pharmaceutical markets, variation in the arrival time of consumer heterogeneity creates differences between a producer’s ability to extract consumer surplus with preventives and treatments, potentially distorting R&D decisions. If consumers vary only in disease risk, reven...
WORKING PAPERS
January 05, 2009
The debate on user fees in health and education has been contentious, but until recently much of the evidence has been anecdotal. Does charging poor people for health and education services improve or impede access? CGD non-resident fellow Michael Kremer and co-author Alaka Holla survey the evidence...